biomedical research

These are the people who want to buy 23andMe

These are the people who want to buy 23andMe

Micheal

Spit into a test tube, send it to Silicon Valley, then sit back and wait for information about your ancestry ...

Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

Personalized vaccine offers hope for patients with late-stage kidney cancer, clinical trial shows

Micheal

Researchers, in a sense, manipulated each patient’s cancer in an attempt to prevent it from coming back. Read More

The truth about cannabis: Researchers from largest study on its effects on the brain have a warning for young adults

The truth about cannabis: Researchers from largest study on its effects on the brain have a warning for young adults

Micheal

The myth that cannabis is harmless because it’s natural has been further debunked—by scientists in a pot-friendly state. Read More

Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says

Lilly weight-loss pill orforglipron could get FDA approval in 2026, CEO Dave Ricks says

Micheal

Eli Lilly & Co., the Fortune 500 pharma firm that manufactures weight-loss injection Zepbound (tirzepatide), has a comparable oral medication ...

Regeneron, Illumina, 17 U.S. health systems invest combined $320M in Truveta Genome Project

Regeneron, Illumina, 17 U.S. health systems invest combined $320M in Truveta Genome Project

Micheal

As part of its quest to “discover the science of humanity,” the Truveta Genome Project will gather the de-identified genetic ...

Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.

Moderna says it’s ‘one step closer’ to a norovirus vaccine as the virus spreads across the U.S.

Micheal

Up to 21 million people contract norovirus each year in the U.S. alone, the CDC says. Read More

Merck-AstraZeneca breast cancer drug Lynparza improves long-term survival, clinical trial shows

Merck-AstraZeneca breast cancer drug Lynparza improves long-term survival, clinical trial shows

Micheal

Lynparza (olaparib), a product of Fortune 500 pharmaceutical firm Merck and Fortune 500 Europe company AstraZeneca, showed meaningful improvements in ...